Results 241 to 250 of about 3,122,352 (307)

New light on the HLA-DR immunopeptidomic landscape. [PDF]

open access: yesJ Leukoc Biol
Egholm Bruun Jensen E   +3 more
europepmc   +1 more source

T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation - An Observational Cohort Study. [PDF]

open access: yesTranspl Int
Aberger S   +9 more
europepmc   +1 more source

Acute Myeloid Leukemia With KAT6A::CREBBP Rearrangement: A Rare Entity With Potential Diagnostic Pitfalls

open access: yes
International Journal of Laboratory Hematology, EarlyView.
Adam Lyle   +2 more
wiley   +1 more source

Hypoxia impairs decitabine-induced expression of HLA-DR in acute myeloid leukaemia cell lines.

open access: yesClin Epigenetics
Humphries S   +5 more
europepmc   +1 more source

HLA-DR is a procoagulant

Biochemical and Biophysical Research Communications, 1991
Numerous incidents of thromboembolic complications have been documented in cancer patients and in recipients of mismatched organ transplants. Tumor procoagulants have also been implicated in the process of metastasis. Two protein bands of 35,000 and 28,000 daltons isolated from human ovarian carcinoma possessed procoagulant activity.
M, Chelladurai, K V, Honn, D A, Walz
openaire   +2 more sources

Targeting HLA-DR

Leukemia & Lymphoma, 2009
The MHC class II human leukocyte antigens (HLAs) are 60-kDa transmembrane αβ heterodimers expressed on the cell surface of antigen presenting cells.
Kevin, Tay   +2 more
openaire   +2 more sources

HLA-DR

2019
???????? ?????????????????????????? ???????????????? ????????????????, ?????? ?????????????????? ?????????? ???????????????????? ???????????? ?????? ??????????????????, ???? ?????????? ???? ??????????????. ?? ???????????? ???????????????????????? ?????????????? ?????????????????? ?????????????????? ???????????????????????? HLA-DR ?? ????????????????????
H. Renz, B. Gierten
openaire   +3 more sources

HLA‐DR and monoclonal gammopathy

Tissue Antigens, 1982
The frequencies of the HLA‐DR antigens were compared in 3 groups: a group of 33 patients with multiple myeloma (MM) or Morbus Waldenström (MW); a group of 34 persons with benign monoclonal gammopathy (BMG); and a group of 118 healthy controls. No statistically significant associations were observed.
L, Muylle   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy